Metropolitan Life Insurance CO Poseida Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.76 - $4.13 $5,370 - $8,036	-1,946 Reduced 51.71%	1,817 $5,000
Q2 2023 Aug 10, 2023	BUY	$1.66 - $3.4 $6,246 - $12,794	3,763 New	3,763 $6,000
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $71 - $90	-9 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$8.51 - $11.91 $77,900 - $109,024	9,154 New	9,154 $87.4 Million
Q1 2021 Mar 30, 2023	BUY	$8.51 - $11.91 $77,900 - $109,024	9,154 New	9,154 $87,000
Q1 2021 May 14, 2021	BUY	$8.51 - $11.91 $76 - $107	9 New	9 $87,000

105

38.9M

451K

146K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.